Gare Smith and I recently co-authored an article on corporate social
responsibility ("CSR") and risk management for Executive Counsel magazine. In
the article, "Making Corporate Social Responsibility
Systemic," one issue we discuss is the potential risk to
companies that "claim to have embraced CSR and then simply
point to glossy reports reflecting anecdotal philanthropic
initiatives to demonstrate the degree of their commitment." We
such companies fail to develop the internal policies and
mechanisms necessary to ensure that the correct people, in the
right functional areas, are held accountable for following specific
environmental and social standards. References to good deeds do not
mitigate against the risks associated with lack of internal
commitment and oversight.
We observe that a lack of executive-level oversight with regard
to a company's approach to CSR may leave companies with little
capacity to develop strategic and comprehensive responses to
stakeholder concerns about the social and environmental impacts of
the company's operations.
A copy of the full article is available here (.pdf).
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Foley Hoag will present a 60-minute webinar on Wednesday, January 25, 2017 at 12:30 pm EST offering guidance to in-house counsel on best practices for pharmaceutical and biologics companies in selecting, vetting, and seeking approval for medication product names. The focus will be primarily on the U.S. market, although foreign strategies may be addressed as well.
25 Jan 2017, Seminar, Massachusetts, United States
Please join us on Wednesday, January 25 at the Westin Waltham Hotel for our quarterly New England M&A Forum, which brings the latest in market trends and recent legal developments to the New England M&A professionals' community.
Sellers love them, buyers hate them, but auctions are a mainstay of the M&A landscape. Our panel of experts, led by Foley Hoag partner Bill Kolb, will discuss legal, business and strategic considerations in structuring and participating in auctions from both the buy-side and the sell-side.
On November 9, 2016 Andrew Liazos presented at the New York City Bar. He discussed innovative approaches used by public companies during the 2016 proxy season for disclosing executive compensation practices.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).